An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...

An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, ...

The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...